Archiv SCREENING

Exciting Times

Dr. J. van Empel

Seite 01

2006 Conference Highlights

Seite 07

Enhancing the Efficiency of HTS

Testing Compound Mixtures

U. Warrior, Ph D, D.J. Burns, Abbott Laboratories, USA

Seite 08

Nanopharmaceuticals

Regulatory Aspects and Safety Issues

Dr. David Rickerby, European Commission, IT

Seite 010

Quantitative HTS

A New Screening Platform for Lead Discovery

W. Zheng, PhD, NIH Chemical Genomics Center, USA

Seite 014

Assays and Cellular Targets

Conference in Las Vegas

Seite 016

Optimizing Protein Formulations

Proteins vs. Small Molecules?

S.W.H. Martin, PhD, Pfizer Global R&D, USA

Seite 018

Immunotherapeutics

Peptides as Screening Tools for Epitopes

Dr. A. Beck et al., Centre d’Immunologie Pierre Fabre, FR

Seite 022

Protease-activated Receptor 2

Opportunities for Anti-inflammatory Drug Discovery

Prof. A.L. Harvey, University of Strathclyde, UK

Seite 026

Debut in Europe

High-Content Analysis Europe in Vienna

Seite 027

High Content Screening

Challenges and Opportunities

W.P. Bowen, PhD, TTP LabTech, UK

Seite 028

GPCR Heterodimers

Finding Ligands

Dr. F.H. Marshall, University of Cambridge, UK

Seite 030

Screening for Excipients

Probing Polymorphic Phase Transformations by Raman Spectroscopy

Prof. T. Rades et al., University of Otago, NZ

Seite 033

Counter-diffusion Capillary Crystallization for structural genomics

Prof. J.D. Ng, University of Alabama, USA; Prof. J.M. Garcia-Ruiz, Laboratorio de Estudios Cristalográficos, ES

Seite 036

Systems Biology and Drug Discovery

A New Path in Genome Research

Dipl.-Biol. C. Wierling, Dr. R. Herwig, Max Planck Institute for Molecular Genetics, DE

Seite 039